ICD-10-PCS code XW0DXV5 for Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 is a medical classification as listed by CMS under Anatomical Regions range.
Section(X) | Body System(W) | Operation(0) | Body Part(D) | Approach(X) | Device / Substance / Technology(V) | Qualifier(5) |
New Technology | Anatomical Regions | Introduction | Mouth and Pharynx | External | COVID-19 Vaccine Dose 3 | New Technology Group 5 |
No record found
Change Type | Change Date | Previous Descriptor |
Code Added | 10-01-2019 |